Trial intelligence / Profile preview

Voclosporin in quiescent non-infectious uveitis

NCT00404742Phase 3Completed

Sponsor
Lux Biosciences, Inc.
Start
Jan 2007
Primary completion
Nov 2008
Modality
Small Molecules
Countries
7
01

Overview

A Phase 3 trial of voclosporin in intermediate uveitis (IU), posterior uveitis, panuveitis, sponsored by Lux Biosciences, Inc.. Started Jan 2007; status: completed.

02

Drugs

voclosporin
03

Conditions

intermediate uveitis (IU)posterior uveitispanuveitis

Beyond the preview

Go deeper on NCT00404742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00404742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call